Big Blog

Arts & Culture
Banking
Biological Science
Blog Watch
Celebrities
Computer Games
Computer Security
Cricket
Data Privacy
Developer
Domain Names
E-commerce
Gadgets
General Science
Handhelds
IP & Patents
Java
Linux
Mobile Technology
Movie Reviews
MP3
Nanotech
Online Auctions
Online Legal Issues
Open Source
Personal Finance
Photography
Quirky
Robotics
Search Engines
Space Science
Top Internet
Top Stories
Top Tech
Video Games
Web Developer
Webmaster Tips
XML & Metadata
{Home}



metastatic: search

Abraxis BioScience Reports Gains in Financial Results for the Third Quarter of 2008

ABRAXANE share in second line metastatic breast cancer achieves all time high of 42% of the taxane market

Oct. 22, 2008--Do Cell Phones Increase Brain Cancer Risk?

The breathing, heart rates and cortisol levels of women with metastatic breast cancer can be used to predict if they'll suffer from chronic insomnia and sleep disruptions, according to a study by scientists at the University of Rochester Medical Center.

Humanities 101: Poetry and Paintings Enter the Residency Curriculum

Internal medicine resident Xu Wang, M.D., Ph.D., was debating how to treat a critically ill woman with metastatic ovarian cancer. Should he perform an intubation—an invasive, painful procedure—to prolong her life, even if it would not cure her disease? Or were palliative measures more appropriate? The patient's family, Wang decided, should have the final say, and so he presented them with both options.

ScinoPharm wins new US patent for crystal forms of oncology product

ScinoPharm, a supplier of active pharmaceutical ingredients, has received a new US patent, which provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.

ScinoPharm gets US patent for novel crystal forms of Irinotecan Hydrochloride

ScinoPharm, an active pharmaceutical ingredient (API) specialist, has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.

ScinoPharm Granted US Patent for Novel Crystal Forms

PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.

ScinoPharm Granted US Patent for Novel Crystal Forms

TAINAN, Taiwan, Nov. 25 /PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.

ScinoPharm Granted US Patent for Novel Crystal Forms

TAINAN, Taiwan, Nov. 25 /PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.

ScinoPharm Granted US Patent for Novel Crystal Forms

TAINAN, Taiwan, November 25, 2008 /PRNewswire-Asia/ -- ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled "Novel Crystal Forms of Irinotecan Hydrochloride." The new patent provides for novel crystalline forms of irinotecan hydrochloride and processes for their preparation as well as pharmaceutical compositions containing the new forms and methods of treating metastatic carcinoma of the colon or rectum using these new forms.


Search News:


Copyright © 2001-2008 Jonathan Hedley